رجوع
مُدرج أيضًا باسم
FMCQF
OTC
نطاق اليوم
KWD 21.91
KWD 22.14
نطاق 52 أسبوعًا
KWD 20.95
KWD 30.46
حجم التداول
445,450
متوسط 50 يوم / 200 يوم
KWD 23.04
/
KWD 24.94
الإغلاق السابق
KWD 21.90
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 13.0 | 0.3 |
| P/B | 0.9 | 2.9 |
| ROE % | 6.8 | 3.7 |
| Net Margin % | 5.0 | 3.8 |
| Rev Growth 5Y % | 2.7 | 10.0 |
| D/E | 0.8 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 28.000
+27.1%
مكرر الربحية المستقبلي
10.7
ربحية السهم المستقبلية
KWD 2.051
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
20 B
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 3.240
KWD 3.121 – KWD 3.422
|
23 B | 1 |
| FY2029 |
KWD 2.936
KWD 2.828 – KWD 3.101
|
22 B | 1 |
| FY2028 |
KWD 2.515
KWD 2.422 – KWD 2.656
|
21 B | 2 |
النقاط الرئيسية
Revenue grew 2.74% annually over 5 years — modest growth
Earnings grew 81.81% over the past year
Generating 1.70B in free cash flow
P/E of 12.98 — trading at a low valuation
PEG of 0.14 suggests growth is underpriced
Cash machine — converts 173.41% of earnings into free cash flow
النمو
Revenue Growth (5Y)
2.74%
Revenue (1Y)1.51%
Earnings (1Y)81.81%
FCF Growth (3Y)-6.60%
الجودة
Return on Equity
6.78%
ROIC5.46%
Net Margin4.98%
Op. Margin9.31%
الأمان
Debt / Equity
0.76
Current Ratio1.26
Interest Coverage0.00
التقييم
P/E Ratio
12.98
P/B Ratio0.89
EV/EBITDA11.98
Dividend Yield0.03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 1.51% | Revenue Growth (3Y) | 0.45% |
| Earnings Growth (1Y) | 81.81% | Earnings Growth (3Y) | 40.00% |
| Revenue Growth (5Y) | 2.74% | Earnings Growth (5Y) | 0.22% |
| Profitability | |||
| Revenue (TTM) | 19.63B | Net Income (TTM) | 978.00M |
| ROE | 6.78% | ROA | 3.15% |
| Gross Margin | 25.62% | Operating Margin | 9.31% |
| Net Margin | 4.98% | Free Cash Flow (TTM) | 1.70B |
| ROIC | 5.46% | FCF Growth (3Y) | -6.60% |
| Safety | |||
| Debt / Equity | 0.76 | Current Ratio | 1.26 |
| Interest Coverage | 0.00 | Dividend Yield | 0.03% |
| Valuation | |||
| P/E Ratio | 12.98 | P/B Ratio | 0.89 |
| P/S Ratio | 0.65 | PEG Ratio | 0.14 |
| EV/EBITDA | 11.98 | Dividend Yield | 0.03% |
| Market Cap | 12.70B | Enterprise Value | 21.89B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 19.63B | 19.34B | 19.45B | 19.40B | 17.62B |
| Net Income | 978.00M | 537.91M | 499.00M | 673.41M | 969.31M |
| EPS (Diluted) | 1.68 | 0.92 | 0.85 | 0.57 | 0.83 |
| Gross Profit | 5.03B | 4.76B | 4.93B | 4.89B | 4.77B |
| Operating Income | 1.83B | 1.39B | 1.37B | 1.51B | 1.85B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 31.00B | 33.57B | 33.93B | 35.75B | 34.37B |
| Total Liabilities | 16.72B | 17.80B | 19.10B | 20.30B | 20.39B |
| Shareholders' Equity | 14.28B | 14.58B | 13.62B | 13.99B | 12.70B |
| Total Debt | 10.80B | 11.00B | 12.08B | 13.21B | 13.32B |
| Cash & Equivalents | 1.60B | 1.18B | 1.40B | 1.27B | 1.48B |
| Current Assets | 7.90B | 7.92B | 8.70B | 8.20B | 7.97B |
| Current Liabilities | 6.25B | 5.66B | 6.11B | 6.47B | 7.26B |